Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review
Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Tahlan, Sumit [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© The Author(s) 2019 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Chemistry central journal - London : BioMed Central, 2007, 13(2019), 1 vom: 06. Aug. |
|---|---|
| Übergeordnetes Werk: |
volume:13 ; year:2019 ; number:1 ; day:06 ; month:08 |
| Links: |
|---|
| DOI / URN: |
10.1186/s13065-019-0625-4 |
|---|
| Katalog-ID: |
SPR030138299 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR030138299 | ||
| 003 | DE-627 | ||
| 005 | 20230519155849.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13065-019-0625-4 |2 doi | |
| 035 | |a (DE-627)SPR030138299 | ||
| 035 | |a (SPR)s13065-019-0625-4-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tahlan, Sumit |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2019 | ||
| 520 | |a Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety. | ||
| 650 | 4 | |a Benzimidazole derivatives |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Antiprotozoal activity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Anti-inflammatory activity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Antimalarial activity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Antimycobacterial activity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Antiviral activity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Anticancer activity |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Kumar, Sanjiv |4 aut | |
| 700 | 1 | |a Narasimhan, Balasubramanian |0 (orcid)0000-0002-9627-094X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chemistry central journal |d London : BioMed Central, 2007 |g 13(2019), 1 vom: 06. Aug. |w (DE-627)525475176 |w (DE-600)2272440-0 |x 1752-153X |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2019 |g number:1 |g day:06 |g month:08 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s13065-019-0625-4 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a GBV_ILN_2027 | ||
| 912 | |a GBV_ILN_4305 | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2019 |e 1 |b 06 |c 08 | ||
| author_variant |
s t st s k sk b n bn |
|---|---|
| matchkey_str |
article:1752153X:2019----::hraooiasgiiacohtrcci1bniiao |
| hierarchy_sort_str |
2019 |
| publishDate |
2019 |
| allfields |
10.1186/s13065-019-0625-4 doi (DE-627)SPR030138299 (SPR)s13065-019-0625-4-e DE-627 ger DE-627 rakwb eng Tahlan, Sumit verfasserin aut Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2019 Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety. Benzimidazole derivatives (dpeaa)DE-He213 Antiprotozoal activity (dpeaa)DE-He213 Anti-inflammatory activity (dpeaa)DE-He213 Antimalarial activity (dpeaa)DE-He213 Antimycobacterial activity (dpeaa)DE-He213 Antiviral activity (dpeaa)DE-He213 Anticancer activity (dpeaa)DE-He213 Kumar, Sanjiv aut Narasimhan, Balasubramanian (orcid)0000-0002-9627-094X aut Enthalten in Chemistry central journal London : BioMed Central, 2007 13(2019), 1 vom: 06. Aug. (DE-627)525475176 (DE-600)2272440-0 1752-153X nnns volume:13 year:2019 number:1 day:06 month:08 https://dx.doi.org/10.1186/s13065-019-0625-4 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_2003 GBV_ILN_2027 GBV_ILN_4305 AR 13 2019 1 06 08 |
| spelling |
10.1186/s13065-019-0625-4 doi (DE-627)SPR030138299 (SPR)s13065-019-0625-4-e DE-627 ger DE-627 rakwb eng Tahlan, Sumit verfasserin aut Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2019 Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety. Benzimidazole derivatives (dpeaa)DE-He213 Antiprotozoal activity (dpeaa)DE-He213 Anti-inflammatory activity (dpeaa)DE-He213 Antimalarial activity (dpeaa)DE-He213 Antimycobacterial activity (dpeaa)DE-He213 Antiviral activity (dpeaa)DE-He213 Anticancer activity (dpeaa)DE-He213 Kumar, Sanjiv aut Narasimhan, Balasubramanian (orcid)0000-0002-9627-094X aut Enthalten in Chemistry central journal London : BioMed Central, 2007 13(2019), 1 vom: 06. Aug. (DE-627)525475176 (DE-600)2272440-0 1752-153X nnns volume:13 year:2019 number:1 day:06 month:08 https://dx.doi.org/10.1186/s13065-019-0625-4 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_2003 GBV_ILN_2027 GBV_ILN_4305 AR 13 2019 1 06 08 |
| allfields_unstemmed |
10.1186/s13065-019-0625-4 doi (DE-627)SPR030138299 (SPR)s13065-019-0625-4-e DE-627 ger DE-627 rakwb eng Tahlan, Sumit verfasserin aut Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2019 Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety. Benzimidazole derivatives (dpeaa)DE-He213 Antiprotozoal activity (dpeaa)DE-He213 Anti-inflammatory activity (dpeaa)DE-He213 Antimalarial activity (dpeaa)DE-He213 Antimycobacterial activity (dpeaa)DE-He213 Antiviral activity (dpeaa)DE-He213 Anticancer activity (dpeaa)DE-He213 Kumar, Sanjiv aut Narasimhan, Balasubramanian (orcid)0000-0002-9627-094X aut Enthalten in Chemistry central journal London : BioMed Central, 2007 13(2019), 1 vom: 06. Aug. (DE-627)525475176 (DE-600)2272440-0 1752-153X nnns volume:13 year:2019 number:1 day:06 month:08 https://dx.doi.org/10.1186/s13065-019-0625-4 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_2003 GBV_ILN_2027 GBV_ILN_4305 AR 13 2019 1 06 08 |
| allfieldsGer |
10.1186/s13065-019-0625-4 doi (DE-627)SPR030138299 (SPR)s13065-019-0625-4-e DE-627 ger DE-627 rakwb eng Tahlan, Sumit verfasserin aut Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2019 Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety. Benzimidazole derivatives (dpeaa)DE-He213 Antiprotozoal activity (dpeaa)DE-He213 Anti-inflammatory activity (dpeaa)DE-He213 Antimalarial activity (dpeaa)DE-He213 Antimycobacterial activity (dpeaa)DE-He213 Antiviral activity (dpeaa)DE-He213 Anticancer activity (dpeaa)DE-He213 Kumar, Sanjiv aut Narasimhan, Balasubramanian (orcid)0000-0002-9627-094X aut Enthalten in Chemistry central journal London : BioMed Central, 2007 13(2019), 1 vom: 06. Aug. (DE-627)525475176 (DE-600)2272440-0 1752-153X nnns volume:13 year:2019 number:1 day:06 month:08 https://dx.doi.org/10.1186/s13065-019-0625-4 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_2003 GBV_ILN_2027 GBV_ILN_4305 AR 13 2019 1 06 08 |
| allfieldsSound |
10.1186/s13065-019-0625-4 doi (DE-627)SPR030138299 (SPR)s13065-019-0625-4-e DE-627 ger DE-627 rakwb eng Tahlan, Sumit verfasserin aut Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2019 Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety. Benzimidazole derivatives (dpeaa)DE-He213 Antiprotozoal activity (dpeaa)DE-He213 Anti-inflammatory activity (dpeaa)DE-He213 Antimalarial activity (dpeaa)DE-He213 Antimycobacterial activity (dpeaa)DE-He213 Antiviral activity (dpeaa)DE-He213 Anticancer activity (dpeaa)DE-He213 Kumar, Sanjiv aut Narasimhan, Balasubramanian (orcid)0000-0002-9627-094X aut Enthalten in Chemistry central journal London : BioMed Central, 2007 13(2019), 1 vom: 06. Aug. (DE-627)525475176 (DE-600)2272440-0 1752-153X nnns volume:13 year:2019 number:1 day:06 month:08 https://dx.doi.org/10.1186/s13065-019-0625-4 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_2003 GBV_ILN_2027 GBV_ILN_4305 AR 13 2019 1 06 08 |
| language |
English |
| source |
Enthalten in Chemistry central journal 13(2019), 1 vom: 06. Aug. volume:13 year:2019 number:1 day:06 month:08 |
| sourceStr |
Enthalten in Chemistry central journal 13(2019), 1 vom: 06. Aug. volume:13 year:2019 number:1 day:06 month:08 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Benzimidazole derivatives Antiprotozoal activity Anti-inflammatory activity Antimalarial activity Antimycobacterial activity Antiviral activity Anticancer activity |
| isfreeaccess_bool |
true |
| container_title |
Chemistry central journal |
| authorswithroles_txt_mv |
Tahlan, Sumit @@aut@@ Kumar, Sanjiv @@aut@@ Narasimhan, Balasubramanian @@aut@@ |
| publishDateDaySort_date |
2019-08-06T00:00:00Z |
| hierarchy_top_id |
525475176 |
| id |
SPR030138299 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR030138299</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519155849.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/s13065-019-0625-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR030138299</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s13065-019-0625-4-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tahlan, Sumit</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s) 2019</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Benzimidazole derivatives</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiprotozoal activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-inflammatory activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antimalarial activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antimycobacterial activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiviral activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticancer activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kumar, Sanjiv</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Narasimhan, Balasubramanian</subfield><subfield code="0">(orcid)0000-0002-9627-094X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Chemistry central journal</subfield><subfield code="d">London : BioMed Central, 2007</subfield><subfield code="g">13(2019), 1 vom: 06. Aug.</subfield><subfield code="w">(DE-627)525475176</subfield><subfield code="w">(DE-600)2272440-0</subfield><subfield code="x">1752-153X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:1</subfield><subfield code="g">day:06</subfield><subfield code="g">month:08</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/s13065-019-0625-4</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2019</subfield><subfield code="e">1</subfield><subfield code="b">06</subfield><subfield code="c">08</subfield></datafield></record></collection>
|
| author |
Tahlan, Sumit |
| spellingShingle |
Tahlan, Sumit misc Benzimidazole derivatives misc Antiprotozoal activity misc Anti-inflammatory activity misc Antimalarial activity misc Antimycobacterial activity misc Antiviral activity misc Anticancer activity Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review |
| authorStr |
Tahlan, Sumit |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)525475176 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1752-153X |
| topic_title |
Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review Benzimidazole derivatives (dpeaa)DE-He213 Antiprotozoal activity (dpeaa)DE-He213 Anti-inflammatory activity (dpeaa)DE-He213 Antimalarial activity (dpeaa)DE-He213 Antimycobacterial activity (dpeaa)DE-He213 Antiviral activity (dpeaa)DE-He213 Anticancer activity (dpeaa)DE-He213 |
| topic |
misc Benzimidazole derivatives misc Antiprotozoal activity misc Anti-inflammatory activity misc Antimalarial activity misc Antimycobacterial activity misc Antiviral activity misc Anticancer activity |
| topic_unstemmed |
misc Benzimidazole derivatives misc Antiprotozoal activity misc Anti-inflammatory activity misc Antimalarial activity misc Antimycobacterial activity misc Antiviral activity misc Anticancer activity |
| topic_browse |
misc Benzimidazole derivatives misc Antiprotozoal activity misc Anti-inflammatory activity misc Antimalarial activity misc Antimycobacterial activity misc Antiviral activity misc Anticancer activity |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Chemistry central journal |
| hierarchy_parent_id |
525475176 |
| hierarchy_top_title |
Chemistry central journal |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)525475176 (DE-600)2272440-0 |
| title |
Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review |
| ctrlnum |
(DE-627)SPR030138299 (SPR)s13065-019-0625-4-e |
| title_full |
Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review |
| author_sort |
Tahlan, Sumit |
| journal |
Chemistry central journal |
| journalStr |
Chemistry central journal |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
txt |
| author_browse |
Tahlan, Sumit Kumar, Sanjiv Narasimhan, Balasubramanian |
| container_volume |
13 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Tahlan, Sumit |
| doi_str_mv |
10.1186/s13065-019-0625-4 |
| normlink |
(ORCID)0000-0002-9627-094X |
| normlink_prefix_str_mv |
(orcid)0000-0002-9627-094X |
| title_sort |
pharmacological significance of heterocyclic 1h-benzimidazole scaffolds: a review |
| title_auth |
Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review |
| abstract |
Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety. © The Author(s) 2019 |
| abstractGer |
Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety. © The Author(s) 2019 |
| abstract_unstemmed |
Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety. © The Author(s) 2019 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_22 GBV_ILN_2003 GBV_ILN_2027 GBV_ILN_4305 |
| container_issue |
1 |
| title_short |
Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review |
| url |
https://dx.doi.org/10.1186/s13065-019-0625-4 |
| remote_bool |
true |
| author2 |
Kumar, Sanjiv Narasimhan, Balasubramanian |
| author2Str |
Kumar, Sanjiv Narasimhan, Balasubramanian |
| ppnlink |
525475176 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.1186/s13065-019-0625-4 |
| up_date |
2024-07-03T14:11:59.276Z |
| _version_ |
1803567412575993856 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR030138299</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519155849.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/s13065-019-0625-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR030138299</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s13065-019-0625-4-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tahlan, Sumit</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s) 2019</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Benzimidazole derivatives</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiprotozoal activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-inflammatory activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antimalarial activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antimycobacterial activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiviral activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticancer activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kumar, Sanjiv</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Narasimhan, Balasubramanian</subfield><subfield code="0">(orcid)0000-0002-9627-094X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Chemistry central journal</subfield><subfield code="d">London : BioMed Central, 2007</subfield><subfield code="g">13(2019), 1 vom: 06. Aug.</subfield><subfield code="w">(DE-627)525475176</subfield><subfield code="w">(DE-600)2272440-0</subfield><subfield code="x">1752-153X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:1</subfield><subfield code="g">day:06</subfield><subfield code="g">month:08</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/s13065-019-0625-4</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2019</subfield><subfield code="e">1</subfield><subfield code="b">06</subfield><subfield code="c">08</subfield></datafield></record></collection>
|
| score |
7.400133 |